A Genome-wide Association and Admixture Mapping Study of Bronchodilator Drug Response in African Americans with Asthma

Short-acting β2-adrenergic receptor agonists (SABAs) are the most commonly prescribed asthma medications worldwide. Response to SABAs is measured as bronchodilator drug response (BDR), which varies among racial/ethnic groups in the United States. However, the genetic variation that contributes to BDR is largely undefined in African Americans with asthma. To identify genetic variants that may contribute to differences in BDR in African Americans with asthma, we performed a genome-wide association study (GWAS) of BDR in 949 African-American children with asthma, genotyped with the Axiom World Array 4 (Affymetrix, Santa Clara, CA) followed by imputation using 1000 Genomes phase III genotypes. We used linear regression models adjusting for age, sex, body mass index (BMI) and genetic ancestry to test for an association between BDR and genotype at single-nucleotide polymorphisms (SNPs). To increase power and distinguish between shared vs. population-specific associations with BDR in children with asthma, we performed a meta-analysis across 949 African Americans and 1830 Latinos (total = 2779). Finally, we performed genome-wide admixture mapping to identify regions whereby local African or European ancestry is associated with BDR in African Americans. We identified a population-specific association with an intergenic SNP on chromosome 9q21 that was significantly associated with BDR (rs73650726, p = 7.69 × 10−9). A trans-ethnic meta-analysis across African Americans and Latinos identified three additional SNPs within the intron of PRKG1 that were significantly associated with BDR (rs7903366, rs7070958 and rs7081864, p ≤ 5 × 10−8). Our results failed to replicate in three additional populations of 416 Latinos and 1615 African Americans. Our findings indicate that both population-specific and shared genetic variation contributes to differences in BDR in minority children with asthma, and that the genetic underpinnings of BDR may differ between racial/ethnic groups.

[1]  北村 聖.  "The New England Journal of Medicine". , 1962, British medical journal.

[2]  S. E. Avner.  Beta-adrenergic bronchodilators. , 1975, Pediatric clinics of North America.

[3]  S. Liggett,et al.  Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. , 1993, American journal of respiratory cell and molecular biology.

[4]  H. Nelson.  β-Adrenergic Bronchodilators , 1995 .

[5]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[6]  K. Nakao,et al.  cDNA cloning and gene expression of human type Ialpha cGMP-dependent protein kinase. , 1996, Hypertension.

[7]  K. Nakao,et al.  cDNA Cloning and Gene Expression of Human Type Iα cGMP-Dependent Protein Kinase , 1996 .

[8]  J. Ritter,et al.  Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. , 1997, Circulation.

[9]  K. Tasken,et al.  Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1). , 1997, Genomics.

[10]  K. Taskén,et al.  Characterization of the Human Gene Encoding the Type Iα and Type Iβ cGMP-Dependent Protein Kinase (PRKG1) , 1997 .

[11]  R. Erickson,et al.  Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. , 1997, The Journal of clinical investigation.

[12]  P. Klatt,et al.  Defective smooth muscle regulation in cGMP kinase I‐deficient mice , 1998, The EMBO journal.

[13]  D. Thomason,et al.  Impact of genetic polymorphisms of the β2‐adrenergic receptor on albuterol bronchodilator pharmacodynamics , 1999, Clinical pharmacology and therapeutics.

[14]  J. Drazen,et al.  Asthma exacerbations during long term â agonist use : influence of â 2 adrenoceptor polymorphism , 2000 .

[15]  E. Silverman,et al.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. , 2000, American journal of respiratory and critical care medicine.

[16]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[17]  T. Jartti.  Asthma, asthma medication and autonomic nervous system dysfunction. , 2001, Clinical physiology.

[18]  L. Palmer,et al.  Pharmacogenetics of asthma. , 2002, American journal of respiratory and critical care medicine.

[19]  M. Salathe,et al.  Effects of β-agonists on airway epithelial cells ☆ ☆☆ , 2002 .

[20]  M. Salathe.  Effects of beta-agonists on airway epithelial cells. , 2002, The Journal of allergy and clinical immunology.

[21]  F. Hofmann,et al.  A Stimulatory Role for cGMP-Dependent Protein Kinase in Platelet Activation , 2003, Cell.

[22]  S. Shore,et al.  Regulation of beta-adrenergic responses in airway smooth muscle. , 2003, Respiratory physiology & neurobiology.

[23]  N. Risch,et al.  The importance of race and ethnic background in biomedical research and clinical practice. , 2003, The New England journal of medicine.

[24]  N. Laird,et al.  Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. , 2003, The Journal of allergy and clinical immunology.

[25]  S. Shore,et al.  Regulation of β-adrenergic responses in airway smooth muscle , 2003, Respiratory Physiology & Neurobiology.

[26]  Edwin K Silverman,et al.  Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. , 2004, American journal of respiratory and critical care medicine.

[27]  E. Silverman,et al.  Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. , 2005, American journal of respiratory and critical care medicine.

[28]  S. Weiss,et al.  Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways. , 2005, Human molecular genetics.

[29]  M. Plummer,et al.  CODA: convergence diagnosis and output analysis for MCMC , 2006 .

[30]  E. Burchard,et al.  Ethnic-Specific Differences in Bronchodilator Responsiveness Among African Americans, Puerto Ricans, and Mexicans with Asthma , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.

[31]  D. Curran‐Everett,et al.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[32]  J. P. Brennan,et al.  Cysteine Redox Sensor in PKGIa Enables Oxidant-Induced Activation , 2007, Science.

[33]  J. Xu,et al.  Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma , 2008, Pharmacogenetics and genomics.

[34]  Hartmut Derendorf,et al.  Population pharmacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthma. , 2008, Chest.

[35]  E. Bleecker,et al.  ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. , 2008, American journal of respiratory and critical care medicine.

[36]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[37]  David H. Alexander,et al.  Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.

[38]  C. Winkler,et al.  Admixture mapping comes of age. , 2010, Annual review of genomics and human genetics.

[39]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[40]  E. Burchard,et al.  Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma. , 2010, The Journal of allergy and clinical immunology.

[41]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[42]  M. Loza,et al.  Regulation of T cells in airway disease by beta-agonist. , 2010, Frontiers in bioscience.

[43]  Francisco M. De La Vega,et al.  Genomics for the world , 2011, Nature.

[44]  Ryan D. Hernandez,et al.  Meta-analysis of Genome-wide Association Studies of Asthma In Ethnically Diverse North American Populations , 2011, Nature Genetics.

[45]  J. Marchini,et al.  Genotype Imputation with Thousands of Genomes , 2011, G3: Genes | Genomes | Genetics.

[46]  Xin Li,et al.  Haplotype inference. , 2012, Methods in molecular biology.

[47]  Yusuke Nakamura,et al.  Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene , 2012, PLoS genetics.

[48]  Ryan D. Hernandez,et al.  Case-control admixture mapping in Latino populations enriches for known asthma-associated genes. , 2012, The Journal of allergy and clinical immunology.

[49]  O. Delaneau,et al.  Haplotype inference. , 2012, Methods in molecular biology.

[50]  Pedro C. Avila,et al.  Fast and accurate inference of local ancestry in Latino populations , 2012, Bioinform..

[51]  Eurie L. Hong,et al.  Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.

[52]  Christopher R. Gignoux,et al.  Factors associated with degree of atopy in Latino children in a nationwide pediatric sample: the Genes-environments and Admixture in Latino Asthmatics (GALA II) study. , 2013, The Journal of allergy and clinical immunology.

[53]  A. Litonjua,et al.  A polymorphism in the thyroid hormone receptor gene is associated with bronchodilator response in asthmatics , 2011, The Pharmacogenomics Journal.

[54]  C. Bustamante,et al.  RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference. , 2013, American journal of human genetics.

[55]  Esteban G Burchard,et al.  Early-life air pollution and asthma risk in minority children. The GALA II and SAGE II studies. , 2013, American journal of respiratory and critical care medicine.

[56]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[57]  J. Celedón,et al.  A genome-wide association study of bronchodilator response in asthmatics , 2013, The Pharmacogenomics Journal.

[58]  Pui-Yan Kwok,et al.  Gene-based association identifies SPATA13-AS1 as a pharmacogenomic predictor of inhaled short-acting beta-agonist response in multiple population groups , 2014, The Pharmacogenomics Journal.

[59]  Ryan D. Hernandez,et al.  A genome-wide association study of bronchodilator response in Latinos implicates rare variants. , 2014, The Journal of allergy and clinical immunology.

[60]  Carlos Bustamante,et al.  Genome-wide association study and admixture mapping identify different asthma-associated loci in Latinos: the Genes-environments & Admixture in Latino Americans study. , 2014, The Journal of allergy and clinical immunology.

[61]  E. Burchard,et al.  Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma. , 2015, Chest.

[62]  David V Conti,et al.  Genetic ancestry influences asthma susceptibility and lung function among Latinos. , 2015, The Journal of allergy and clinical immunology.

[63]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[64]  R. Wu,et al.  Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3. , 2015, American journal of respiratory and critical care medicine.

[65]  Wei Zheng,et al.  Addressing Population‐Specific Multiple Testing Burdens in Genetic Association Studies , 2015, Annals of human genetics.

[66]  E. Burchard,et al.  Novel genetic risk factors for asthma in African American children: Precision Medicine and the SAGE II Study , 2016, Immunogenetics.

[67]  E. Burchard,et al.  Towards Equity in Health: Researchers Take Stock , 2016, PLoS medicine.

[68]  S. Fullerton,et al.  Genomics is failing on diversity , 2016, Nature.

[69]  John Novembre,et al.  Visualizing the geography of genetic variants , 2016, bioRxiv.